Transforming healthcare with innovative diagnostics
We’re working to improve diagnostic devices for diabetes, immune-related bowel disease, cancer, and genomics. By building the right systems and infrastructure, we aim to ensure these tests are accurate, effective, and affordable—helping patients to get the right care faster. Our research focuses on both lab-based and real-world diagnostics to improve health outcomes and make a real difference to people’s lives.
The critical role of diagnostics in healthcare
Diagnostics are essential in the NHS, helping doctors detect diseases, predict outcomes, and tailor treatments for personalised care. While new diagnostic technologies offer great potential, proving their effectiveness, safety, and impact is complex, slowing their implementation. Expertise, collaboration and high-quality evidence are key to ensuring new tests reach patients quickly and effectively.
Leaders in diagnostic innovation and patient involvement
We’re at the forefront of developing, evaluating, and implementing cutting-edge diagnostics for conditions like diabetes, dementia, cancer, and immune-related diseases. Our work bridges the gap between research and real-world application, ensuring new technologies meet NHS and regulatory standards.
People are at the heart of our research. By working with the Exeter Clinical Trials Unit we involve people in research that could directly benefit them. We also collaborate with major diagnostic manufacturers, leading universities, and hospitals to expand our research and clinical testing.
Collaborating for better health outcomes
Partnerships are key to driving innovation in diagnostics. We collaborate with major partners to develop diagnostic tools for diabetes, Crohn’s disease, and cancer, bringing together experts across disciplines to accelerate the assessment and adoption of cutting-edge diagnostics. We also work with charities, patient groups and healthcare partners to evaluate new diagnostics, improving patient care and healthcare through a dedicated pipeline.